SCHEMBL5936618

SCHEMBL5936618

O=C([CH]c1cccc(OCc2ccccc2)c1)c1cccc(OCCN(Cc2ccccc2)Cc2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.52
MAOB P27338 4/20 0.50
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
PKM P14618 1/20 0.50
MAOA P21397 2/20 0.49
SMPD1 P17405 1/20 0.48
LMNA P02545 1/20 0.48
THRB P10828 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KMT2A Q03164 2/20 0.47
SRD5A2 P31213 1/20 0.47
PTPN1 P18031 1/20 0.46
BCHE P06276 1/20 0.46
MEN1 O00255 1/20 0.46
TLR4 O00206 1/20 0.46
TLR2 O60603 1/20 0.46
CCNB2 O95067 1/20 0.46
CDK1 P06493 1/20 0.46
CDK4 P11802 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5936595 0.92 KDM4E (0.51) NR4A2MAOBALDH1A1KDM4ESMN1; SMN2
SCHEMBL5936607 0.86 KDM4E (0.49) NR4A2MAOBALDH1A1KDM4EMAOA
SCHEMBL5936627 0.83 BCHE (0.50) MAOBALDH1A1KDM4EKMT2ABCHE
SCHEMBL5720732 0.80 NR4A2 (0.62) NR4A2MAOBKMT2ASRD5A2
SCHEMBL1122914 0.77 KMT2A (0.51) NR4A2MAOBSMPD1KMT2ASRD5A2
SCHEMBL4505904 0.77 NR4A2 (0.61) NR4A2MAOBKMT2ASRD5A2
SCHEMBL1123557 0.76 PTGES (0.52) NR4A2MAOBSMPD1KMT2APTPN1
SCHEMBL1123394 0.76 KMT2A (0.52) NR4A2MAOBSMPD1KMT2APTPN1
SCHEMBL1122636 0.75 BCHE (0.50) NR4A2MAOBLMNASMN1; SMN2KMT2A
SCHEMBL11561702 0.74 NR4A2 (0.72) NR4A2MAOBALDH1A1KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG NR4A2 66/4885MAOB 1188/4885ALDH1A1 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.